CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2023		84,861,000
Beginning balance at Dec. 31, 2023	$ 2,108,086	$ 8,486	$ 1,808,883	$ 467,305	$ (16,710)	$ (159,878)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income	121,609			86,901		34,708
Stock-based compensation expense	10,233		10,233
Common stock transactions related to stock-based employee benefit plans (in shares)		620,000
Common stock transactions related to stock-based employee benefit plans	972	$ 128	1,934		(1,090)
Repurchase of common stock (in shares)		(40,000)
Repurchase of common stock	(880)				(880)
Dividends on common stock	(46,170)			(46,170)
Increase (decrease) in shares during period (in shares)		580,000
Increase (decrease) in stockholders' equity during period	85,764	$ 128	12,167	40,731	(1,970)	34,708
Ending balance (in shares) at Sep. 30, 2024		85,441,000
Ending balance at Sep. 30, 2024	2,193,850	$ 8,614	1,821,050	508,036	(18,680)	(125,170)
Beginning balance (in shares) at Jun. 30, 2024		85,299,000
Beginning balance at Jun. 30, 2024	2,130,381	$ 8,530	1,815,800	492,805	(18,744)	(168,010)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income	73,491			30,651		42,840
Stock-based compensation expense	4,128		4,128
Common stock transactions related to stock-based employee benefit plans (in shares)		142,000
Common stock transactions related to stock-based employee benefit plans	1,270	$ 84	1,122		64
Dividends on common stock	(15,420)			(15,420)
Increase (decrease) in shares during period (in shares)		142,000
Increase (decrease) in stockholders' equity during period	63,469	$ 84	5,250	15,231	64	42,840
Ending balance (in shares) at Sep. 30, 2024		85,441,000
Ending balance at Sep. 30, 2024	$ 2,193,850	$ 8,614	1,821,050	508,036	(18,680)	(125,170)
Beginning balance (in shares) at Dec. 31, 2024	85,567,712	85,568,000
Beginning balance at Dec. 31, 2024	$ 2,183,243	$ 8,628	1,824,935	526,642	(19,095)	(157,867)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income	177,062			110,618		66,444
Stock-based compensation expense	11,445		11,445
Common stock transactions related to stock-based employee benefit plans (in shares)		426,000
Common stock transactions related to stock-based employee benefit plans	(1,289)	$ 50	370		(1,709)
Issuance of common stock, pursuant to acquisition (in shares)		1,862,000
Issuance of common stock, pursuant to acquisitions	54,547	$ 186	54,361
Dividends on common stock	(46,876)			(46,876)
Increase (decrease) in shares during period (in shares)		2,288,000
Increase (decrease) in stockholders' equity during period	$ 194,889	$ 236	66,176	63,742	(1,709)	66,444
Ending balance (in shares) at Sep. 30, 2025	87,855,718	87,856,000
Ending balance at Sep. 30, 2025	$ 2,378,132	$ 8,864	1,891,111	590,384	(20,804)	(91,423)
Beginning balance (in shares) at Jun. 30, 2025		85,948,000
Beginning balance at Jun. 30, 2025	2,271,565	$ 8,673	1,832,158	569,833	(20,792)	(118,307)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income	63,351			36,467		26,884
Stock-based compensation expense	4,448		4,448
Common stock transactions related to stock-based employee benefit plans (in shares)		46,000
Common stock transactions related to stock-based employee benefit plans	137	$ 5	144		(12)
Issuance of common stock, pursuant to acquisition (in shares)		1,862,000
Issuance of common stock, pursuant to acquisitions	54,547	$ 186	54,361
Dividends on common stock	(15,916)			(15,916)
Increase (decrease) in shares during period (in shares)		1,908,000
Increase (decrease) in stockholders' equity during period	$ 106,567	$ 191	58,953	20,551	(12)	26,884
Ending balance (in shares) at Sep. 30, 2025	87,855,718	87,856,000
Ending balance at Sep. 30, 2025	$ 2,378,132	$ 8,864	$ 1,891,111	$ 590,384	$ (20,804)	$ (91,423)